AstraZeneca (AZNCF, $99.60) vaccine linked to deadly blood clots in rare instances
The coronavirus vaccine developed by AstraZeneca PLC has been linked to an autoimmune reaction that can lead to deadly blood clots in rare instances, according to a study by researchers in Norway and Germany.
According to the researchers in Norway and Germany, the vaccine could trigger an autoimmune reaction that causes blood to clot in the brain, the Wall Street Journal reported. The research could lead to a possible treatment to prevent the problem, the paper said. Symptoms such as dizziness and blurred vision occur several days after the vaccine is administered. But the condition can be detected by a simple blood test and easily treated in a hospital, according to the report.
Last week, there was a brief halting of the AstraZeneca vaccine rollout in Europe after several people who received the vaccine died. But later in the week, EU regulators allowed the use of the vaccine, after assessing that benefits far outweighed the risks of the vaccine.
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), AstraZeneca PLC (NASDAQ:AZN), Pfizer (NYSE:PFE), Bristol-Myers Squibb Co (NYSE:BMY), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Biogen (NASDAQ:BIIB).
The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.
The average market capitalization across the Pharmaceuticals: Major Industry is 80.33B. The market cap for tickers in the group ranges from 72.83K to 404.19B. LLY holds the highest valuation in this group at 404.19B. The lowest valued company is CRXTQ at 72.83K.
High and low price notable news
The average weekly price growth across all stocks in the Pharmaceuticals: Major Industry was -2%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was 2%. SNPHF experienced the highest price growth at 7%, while SCLX experienced the biggest fall at -12%.
The average weekly volume growth across all stocks in the Pharmaceuticals: Major Industry was -11%. For the same stocks of the Industry, the average monthly volume growth was -5% and the average quarterly volume growth was 125%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 28
P/E Growth Rating: 56
Price Growth Rating: 53
SMR Rating: 52
Profit Risk Rating: 59
Seasonality Score: 17 (-100 ... +100)